Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol-enhanced MRI for Coronary Artery Visualization
NCT06348524Phase 3Terminated
- Sponsor
- TRANSMED SOLUTIONS
- Start
- Jan 2015
- Primary completion
- Dec 2022
- Modality
- Nanoparticles, Small Molecules
01
Overview
A Phase 3 trial of ferumoxytol in coronary artery disease (CAD), sponsored by TRANSMED SOLUTIONS. Started Jan 2015; status: terminated.
02
Drugs
ferumoxytol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT06348524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06348524.